跳至主要内容
临床试验/NCT02244528
NCT02244528已完成2 期

Pharmacokinetic Study of Sildenafil in Neonates and Preterm Infants

Seoul National University Hospital2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
20
试验地点
2
主要终点
AUC(0-t)

研究概览

简要总结

The purpose of this study is to investigate the pharmacokinetics of sildenafil which is used as treatment of pulmonary hypertension in neonate and preterm infant.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 1 Month(Child)
性别
All
接受健康志愿者

入选标准

  • Admitted at NICU in Seoul National University Hospital or Bundang Seoul National University hospital
  • Infants who were diagnosed with PAH

排除标准

  • Severe allergic reaction to sildenafil
  • Inotropics for hypotension within 3 days prior to enrollment
  • AST or ALT > 3x ULN
  • Any condition that would make the participant, in the opinion of the investigator, unsuitable for the stud

研究组 & 干预措施

Treatment

Experimental

sildenafil treatment

干预措施: Sildenafil (Drug)

结局指标

主要结局

AUC(0-t)

时间窗: t up to 5 weeks

5 times drug level after 5 doses (pre30min/post 30min, 1hr, 2hr, 4hr) pharmacokinetics

Cmax(0-t)

时间窗: t up to 5 weeks

5 times drug level after 5 doses (pre30min/post 30min, 1hr, 2hr, 4hr) pharmacokinetics

次要结局

  • Change from baseline in pulmonary arterial hypertension at 5 weeks(pre, 2 weeks, 5 weeks of drug administration)
  • respiratory severity score(pre, 2 weeks, 5 weeks after administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Han-Suk Kim

Professor

Seoul National University Hospital

研究点 (2)

Loading locations...

相似试验

PK Study of Sildenafil in Neonate | 临床试验